Pharmaceutical company AstraZeneca stated on Tuesday, May 7, that it had initiated a worldwide withdrawal of its COVID-19 vaccine due to a “surplus of available updated vaccines.”
The company also claimed it would continue to withdraw marketing authorisations for its Vaxzevria vaccine in Europe.
As multiple, variant COVID-19 vaccines have since been developed there is a surplus of available updated vaccines.
The Anglo-Swedish drug producer has previously admitted in court documents that the vaccine causes side effects, such as blood clots and a drop in blood platelet counts, according to the Telegraph.
AstraZeneca‘s application to recall the vaccine was filed on March 5 and went into effect on May 7.
The company began developing a respiratory syncytial virus vaccine and obesity drugs last year following a slowdown in growth amid declining sales of its COVID-19 drug.
